Protective effect of interleukin-1 receptor antagonist on oleic acid-induced lung injury

Chinese Medical Journal

Volumn 109, Issue 7, 1996, Pages 522-526

  Sun, Dejun ^a   Zhao, Mingwu ^a   Ma, Dalong ^a   Liao, Songlin ^a   Di, Chunhui ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OLEIC ACID; PROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; INTRAVENOUS DRUG ADMINISTRATION; LUNG INJURY; LUNG LAVAGE; LUNG WEIGHT; MALE; MOUSE; NONHUMAN;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; LUNG; MALE; MICE; MICE, INBRED BALB C; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OLEIC ACID; RECEPTORS, INTERLEUKIN-1; RESPIRATORY DISTRESS SYNDROME, ADULT; SIALOGLYCOPROTEINS;

EID: 0029886095     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Suter PM, Suter S, Girardin E, et al. High bronchoalveolar levels of tumor necrosis factor and its inhibitors interleukin-1, interferon and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis 1992; 145:1016.
2. 15N) nitrate in biological fluids. Anal Bioch 1982; 126:131.
3. Zhang XB, Huang HL, Zhang LZ. Measurement and application of nitric oxide synthase activity. J Beijing Med University 1994; 26:173.
4. Beckman JS, Beckman TW, Chen J, et al. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. PNAS 1990; 87:1620.
5. Belmenky SN, Robbins RA, Rennard SI, et al. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro. J Lab Clin Med 1993; 122:388.
6. Knowles RG, Moncada S. Nitric oxide as a single in blood vessels. TiBS 1992; 17:399.
7. Ohlsson K, Bjork P, Bergenfeldt M, et al. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990; 348:550.
8. Wakabayashi G, Gelfand JA, Burke JF, et al. A specific receptor antagonist for interleukin-1 prevents Escherichia Coli-induced shock in rabbits. FASEB J 1991; 5:338.
9. Alexander HR, Donerty GM, Buresh CM, et al. A recombinant human receptor antagonist to interleukin-1 improves survival after lethal endotoxemia in mice. J Exp Med 1991; 173:1029.
10. Gordon GS, Fisher CJ, Slotman GJ, et al. Cost-effectiveness of treatment with interleukin-1 receptor antagonist (IL-1ra in patients with sepsis syndrome. Clin Res 1992; 40:254A.